Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen for schizophrenia.

W L Chua1, Santiago A de Izquierdo, J Kulkarni

  • 1Bradford District Care Trust, City Mental Health Team, Horton Park Centre, 99 Horton Park Avenue, Bradford, West Yorkshire, UK BD7 3 EG. lian.chua@btinternet.com

The Cochrane Database of Systematic Reviews
|October 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase correction in violin ensemble performance.

Scientific reports·2026
Same author

Initial experience using middle meningeal artery embolisation for patients with recurrent and high-recurrence-risk chronic subdural haematoma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2024
Same author

Subjective cognitive changes following premenopausal risk-reducing bilateral salpingo-oophorectomy.

Climacteric : the journal of the International Menopause Society·2023
Same author

Cerebral CT angiography as an ancillary investigation in the diagnosis of death using neurological criteria: a new UK guideline.

Clinical radiology·2023
Same author

The use of cerebral computed tomographic angiography as an ancillary investigation to support a clinical diagnosis of death using neurological criteria: a consensus guideline.

Anaesthesia·2023
Same author

Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2022
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Estrogen therapy, alone or with progesterone, did not show significant benefits for schizophrenia treatment in women. Further research requires access to all completed and unpublished studies to justify new trials.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Endocrinology

Background:

  • Women with schizophrenia exhibit different clinical outcomes than men, with increased vulnerability post-partum and post-menopause.
  • Estrogen withdrawal is linked to these vulnerable periods, suggesting estrogen as a potential schizophrenia treatment.
  • Hormone replacement therapy is being investigated for its effects on psychotic disorders.

Purpose of the Study:

  • To assess the clinical efficacy of estrogens, with or without progesterone, as a standalone or adjunctive therapy for schizophrenia.
  • To evaluate the impact of hormone therapy on psychotic symptoms and cognitive function in women with schizophrenia.

Main Methods:

  • Systematic review of randomized clinical trials comparing estrogens (with or without progesterone) to placebo.

Related Experiment Videos

  • Searches included the Cochrane Schizophrenia Group's Register and manual reference inspection.
  • Data were analyzed independently using intention-to-treat principles, calculating relative risks and weighted mean differences.

    • Main Results:

    • Evidence pertains to women only; four studies (n=108) compared estrogen to placebo, showing no significant differences in general mental state or study attrition.
    • One study (n=14) comparing estrogen and progesterone to placebo found no difference in total scores but favored the hormone group for negative symptoms and visual retention test performance.
    • No clear differences were observed in movement disorders, and study dropout rates were similar across groups.

    Conclusions:

    • Adjunctive estrogen therapy, with or without progesterone, does not provide clear advantages over placebo for schizophrenia treatment.
    • Availability of all completed and unpublished research is crucial before initiating further trials to determine the justification for new studies.
    • Further investigation into hormone therapy for schizophrenia requires a comprehensive understanding of existing evidence.